Effects of NMDA-receptor blockade by ketamine on mentalizing and its neural correlates in humans: a randomized control trial

• Published in: Scientific reports Vol. 13; no. 1; p. 17184
• Main Authors: Wasserthal, Sven, Lehmann, Mirko, Neumann, Claudia, Delis, Achilles, Philipsen, Alexandra, Hurlemann, René, Ettinger, Ulrich, Schultz, Johannes
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 11.10.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378; 631/378/2645; Antipsychotics; Cognitive ability; Cortex (parietal); Emotional behavior; Functional magnetic resonance imaging; Glutamate receptors; Glutamatergic transmission; Glutamic acid receptors (ionotropic); Humanities and Social Sciences; Ketamine; Magnetic resonance imaging; Mental disorders; multidisciplinary; N-Methyl-D-aspartic acid receptors; Placebos; Psychosis; Schizophrenia; Science; Science (multidisciplinary); Social interactions; Superior temporal sulcus
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-44443-6

Schizophrenia is associated with various deficits in social cognition that remain relatively unaltered by antipsychotic treatment. While faulty glutamate signaling has been associated with general cognitive deficits as well as negative symptoms of schizophrenia, no direct link between manipulation of glutamate signaling and deficits in mentalizing has been demonstrated thus far. Here, we experimentally investigated whether ketamine, an uncompetitive N-methyl-D-aspartate receptor antagonist known to induce psychotomimetic effects, influences mentalizing and its neural correlates. In a randomized, placebo-controlled between-subjects experiment, we intravenously administered ketamine or placebo to healthy participants performing a video-based social cognition task during functional magnetic resonance imaging. Psychotomimetic effects of ketamine were assessed using the Positive and Negative Syndrome Scale. Compared to placebo, ketamine led to significantly more psychotic symptoms and reduced mentalizing performance (more “no mentalizing” errors). Ketamine also influenced blood oxygen level dependent (BOLD) response during mentalizing compared to placebo. Specifically, ketamine increased BOLD in right posterior superior temporal sulcus (pSTS) and increased connectivity between pSTS and anterior precuneus. These increases may reflect a dysfunctional shift of attention induced by ketamine that leads to mentalizing deficits. Our findings show that a psychotomimetic dose of ketamine impairs mentalizing and influences its neural correlates, a result compatible with the notion that deficient glutamate signaling may contribute to deficits in mentalizing in schizophrenia. The results also support efforts to seek novel psychopharmacological treatments for psychosis and schizophrenia targeting glutamatergic transmission.